go to main content
Partners News
Results (55)

Filter results

setup e-mail alert

Setup e-mail alerts

An email has been sent. Click on the link in the email to activate your emailalert.
Something went wrong!
Something went wrong while requesting this page. Please try again.
Email address *

  • Would you like to receive e-mail updates?

    Select the frequency of how often you would like to receive an e-mail alert

SPL Medical announces collaboration with NanoEcho for application of Ferrotran® (Ferumoxtran) for Ultrasound detection of Lymph node metastases

30 September 2022

SPL medical and NanoEcho have signed a Letter of Intent and initiated a cooperation on regulatory partnership and supply for SPL medical proprietary iron-based nanoparticle Ferrotran® (Ferumoxtran) product and platform.

Radboudumc Investment Day 2022

26 September 2022

Get ready for Radboudumc Investment Day 2022: October 5 in Nijmegen!

Innovation by Predica Diagnostics BV improves cervical cancer screening

26 July 2022

A joint financing round from ION+2 and the Thematic Technology Transfer Medtech Fund (TTT Medtech) allows the further development of molecular diagnostic tests for different cancers by Predica Diagnostics (Nijmegen, NL).

Xenikos enrolls first patient in global pivotal phase 3 study evaluating T-Guard®

30 June 2022 First patient dosed in their Phase 3 study for T-Guard, a candidate for the treatment of severe acute graft-versus-host disease (aGVHD).

Radboudumc and Terumo Europe N.V. sign collaboration agreement

3 June 2022 Together, the two partners will improve existing treatments for cancer patients and develop new, personalized therapies. Focus will be on the clinical use of holmium-166 microspheres, small radioactive beads.